Skip main navigation

Next generation sulfonyl urea drugs

More information about Next generation sulfonyl urea drugs.
© Monash University 2022. CRICOS No. 00008C

Among the radical changes made to the sulfonyl urea drugs was the addition of large groups on the left hand side of the benzene ring.

In this example, glibenclamide, we can see that the left hand side has been changed dramatically. From the simple variation of amine to methyl to chlorine, we now have a large group with an aromatic ring.

glibenclamide

With the ability to modify the left hand side of these compounds, the drug discovery teams could explore the effect of their changes on efficacy and safety. The profile they were after was one which provided good potency with the right characteristics for a drug. In other words safe and convenient for clinical use. While glibenclamide wasn’t perfect given the variable metabolism between individuals, it led to glipizide which emerged in the 1980s.

Glipizide 648 px

Glipizide also shares the same right hand side as glibenclamide and the substituent on the left is also large and includes an aromatic ring. This compound may be taken twice daily or as a once daily dose using a tablet that slowly releases the drug.

The trend for large left hand side substituents has been reversed in the drug gliclazide. Let’s have a look at it.

gliclazide article 648px

Interestingly, a return to a methyl group has resulted in a very widely used drug. Long acting agents can lead to low sugar levels in the elderly which is an unwanted effect. Hence, the use of a methyl group that allows quicker metabolism of the drug. This lets clinicians tailor the characteristics of the drug to the patient and their condition.

The right hand side of gliclazide is also interesting as it now comprises two fused 5 membered rings that are hydrophobic (or fatty) in nature, corresponding to characteristics of this group in the other members of this drug class.

Summary of sulfonyl urea drug class

With the development of numerous antidiabetic compounds that are based on the sulfonylurea structure, it is possible to draw a simplified molecule that encapsulates all of these compounds.

sulfonylurea 648px

Indeed, we could easily imagine our own structures where we would devise suitable X and Y substituents. Whether our designs would be potent, selective and suitable as drugs is open to conjecture.

© Monash University 2022. CRICOS No. 00008C
This article is from the free online

The Science of Medicines

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education